These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 15201678)

  • 21. The impact of nonalcoholic fatty liver disease and the metabolic syndrome on progression of fibrosis in patients with recurrent HCV after liver transplantation.
    Mindikoglu AL; Regev A; Casanova-Romero PY; Bejarano PA; Martinez EJ; Tzakis AG; Schiff ER
    Transplant Proc; 2006 Jun; 38(5):1440-4. PubMed ID: 16797327
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatitis C virus recurrence after liver transplantation: relationship to anti-HCV core IgM, genotype, and level of viremia.
    Crespo J; Carte B; Lozano JL; Casafont F; Rivero M; de la Cruz F; Pons-Romero F
    Am J Gastroenterol; 1997 Sep; 92(9):1458-62. PubMed ID: 9317062
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fibrosis progression after liver transplantation in patients with recurrent hepatitis C.
    Neumann UP; Berg T; Bahra M; Seehofer D; Langrehr JM; Neuhaus R; Radke C; Neuhaus P
    J Hepatol; 2004 Nov; 41(5):830-6. PubMed ID: 15519657
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [HCV reinfection after liver transplantation for HCV cirrhosis].
    Pasquale G; Iannicelli P; Martini S; Mogavero AR; Caprio N
    Infez Med; 2005 Dec; 13(4):215-28. PubMed ID: 16388277
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of fibrosis progression on clinical outcome in patients treated for post-transplant hepatitis C recurrence.
    Dhanasekaran R; Sanchez W; Mounajjed T; Wiesner RH; Watt KD; Charlton MR
    Liver Int; 2015 Nov; 35(11):2433-41. PubMed ID: 26058570
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Are posttransplantation protocol liver biopsies useful in the long term?
    Berenguer M; Rayón JM; Prieto M; Aguilera V; Nicolás D; Ortiz V; Carrasco D; López-Andujar R; Mir J; Berenguer J
    Liver Transpl; 2001 Sep; 7(9):790-6. PubMed ID: 11552213
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Treatment of recurrent HCV infection after liver transplantation].
    Ostojić R
    Acta Med Croatica; 2005; 59(5):443-6. PubMed ID: 16381241
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tissue hepatitis C virus RNA quantification and protein expression help identify early hepatitis C virus recurrence after liver transplantation.
    D'Errico-Grigioni A; Fiorentino M; Vasuri F; Gruppioni E; Fabbrizio B; Zucchini N; Ballardini G; Morelli C; Pinna AD; Grigioni WF
    Liver Transpl; 2008 Mar; 14(3):313-20. PubMed ID: 18306349
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Successful treatment of fibrosing cholestatic hepatitis after liver transplantation.
    Cimsit B; Assis D; Caldwell C; Arvelakis A; Taddei T; Kulkarni S; Schilsky M; Emre S
    Transplant Proc; 2011 Apr; 43(3):905-8. PubMed ID: 21486625
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Killer cell immunoglobulin-like receptor genotype and killer cell immunoglobulin-like receptor-human leukocyte antigen C ligand compatibility affect the severity of hepatitis C virus recurrence after liver transplantation.
    de Arias AE; Haworth SE; Belli LS; Burra P; Pinzello G; Vangeli M; Minola E; Guido M; Boccagni P; De Feo TM; Torelli R; Cardillo M; Scalamogna M; Poli F
    Liver Transpl; 2009 Apr; 15(4):390-9. PubMed ID: 19326408
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Apolipoprotein E polymorphism influences orthotopic liver transplantation outcomes in patients with hepatitis C virus-induced liver cirrhosis.
    Nascimento JCR; Pereira LC; Rêgo JMC; Dias RP; Silva PGB; Sobrinho SAC; Coelho GR; Brasil IRC; Oliveira-Filho EF; Owen JS; Toniutto P; Oriá RB
    World J Gastroenterol; 2021 Mar; 27(11):1064-1075. PubMed ID: 33776373
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The influence of cytomegalovirus viraemia on the outcome of recurrent hepatitis C after liver transplantation.
    Teixeira R; Pastacaldi S; Davies S; Dhillon AP; Emery VC; Rolles K; Davidson B; Patch D; Burroughs AK
    Transplantation; 2000 Nov; 70(10):1454-8. PubMed ID: 11118089
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of cytokine gene polymorphism and hepatic transforming growth factor beta1 expression in recurrent hepatitis C after liver transplantation.
    Ben-Ari Z; Pappo O; Druzd T; Sulkes J; Klein T; Samra Z; Gadba R; Tambur AR; Tur-Kaspa R; Mor E
    Cytokine; 2004 Jul; 27(1):7-14. PubMed ID: 15207246
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Advancing donor liver age and rapid fibrosis progression following transplantation for hepatitis C.
    Wali M; Harrison RF; Gow PJ; Mutimer D
    Gut; 2002 Aug; 51(2):248-52. PubMed ID: 12117889
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The recurrence of hepatitis C virus after liver transplantation].
    Nemes B; Sárváry E; Gerlei Z; Fazakas J; Doros A; Németh A; Görög D; Fehérvári I; Máthé Z; Gálffy Z; Pár A; Schuller J; Telegdy L; Fehér J; Lotz G; Schaff Z; Nagy P; Járay J; Lengyel G
    Orv Hetil; 2007 Oct; 148(42):1971-9. PubMed ID: 17932003
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Digital image analysis of collagen assessment of progression of fibrosis in recurrent HCV after liver transplantation.
    Manousou P; Burroughs AK; Tsochatzis E; Isgro G; Hall A; Green A; Calvaruso V; Ma GL; Gale J; Burgess G; O'Beirne J; Patch D; Thorburn D; Leandro G; Dhillon AP
    J Hepatol; 2013 May; 58(5):962-8. PubMed ID: 23262247
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Liver transplantation for HCV cirrhosis: improved survival in recent years and increased severity of recurrent disease in female recipients: results of a long term retrospective study.
    Belli LS; Burroughs AK; Burra P; Alberti AB; Samonakis D; Cammà C; De Carlis L; Minola E; Quaglia A; Zavaglia C; Vangeli M; Patch D; Dhillon A; Cillo U; Guido M; Fagiuoli S; Giacomoni A; Slim OA; Airoldi A; Boninsegna S; Davidson BR; Rolles K; Pinzello G
    Liver Transpl; 2007 May; 13(5):733-40. PubMed ID: 17370330
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of different immunosuppression in the long-term histological outcome of HCV reinfection after liver transplantation for HCV cirrhosis.
    Papatheodoridis GV; Davies S; Dhillon AP; Teixeira R; Goulis J; Davidson B; Rolles K; Dusheiko G; Burroughs AK
    Transplantation; 2001 Aug; 72(3):412-8. PubMed ID: 11502968
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term outcome of hepatitis C infection after liver transplantation.
    Gane EJ; Portmann BC; Naoumov NV; Smith HM; Underhill JA; Donaldson PT; Maertens G; Williams R
    N Engl J Med; 1996 Mar; 334(13):815-20. PubMed ID: 8596547
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Outcome of liver transplantation in hepatitis C virus-infected patients who received hepatitis C virus-infected grafts.
    Vargas HE; Laskus T; Wang LF; Lee R; Radkowski M; Dodson F; Fung JJ; Rakela J
    Gastroenterology; 1999 Jul; 117(1):149-53. PubMed ID: 10381921
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.